SCHEMBL901732

SCHEMBL901732

CCC(=O)C(C)(C)C(=O)C(C)(C)C

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.33
FFAR3 O14843 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27770220 0.82 TDP1 (0.41) TDP1
SCHEMBL2545646 0.82 ALDH1A1 (0.41) TDP1FFAR3ALDH1A1
Tetrabuthylammonium SCHEMBL10412518 0.80 SLC22A1 (0.43) ALDH1A1
SCHEMBL8459639 0.79 CES1 (0.39) FFAR3ALDH1A1
SCHEMBL4841349 0.79 FFAR3 (0.36) TDP1FFAR3ALDH1A1
SCHEMBL2468705 0.79 CES2 (0.39)
SCHEMBL6011032 0.77 FFAR3 (0.35) FFAR3ALDH1A1
SCHEMBL8460026 0.76 HMGCR (0.31)
SCHEMBL121296 0.76
SCHEMBL4854338 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100168404-A1 Metal Complex Compositions and Methods for Making Metal-Containing Films THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOI (US) 2010-07-01 US claimed
WO-2008127935-A1 METAL COMPLEX COMPOSITIONS AND METHODS FOR MAKING METAL-CONTAINING FILMS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2008-10-23 WO claimed
US-4956428-A POLYMERIZATION OF ACRYLIC OR MALEIMIDE MONOMER WITH ORGANOSILICON, ORGANOTIN, ORGANOGERMANIUM INITIATORS, COORDINATION CATALYST IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-09-11 US claimed
EP-3328860-B2 PROCESS FOR THE PREPARATION OF BENZIMIDAZO[1,2-A]BENZIMIDAZOLES UDC IRELAND LTD (IE) 2022-11-02 EP disclosed
EP-3328860-B1 PROCESS FOR THE PREPARATION OF BENZIMIDAZO[1,2-A]BENZIMIDAZOLES UDC IRELAND LTD (IE) 2020-03-04 EP disclosed
US-10570136-B2 Process for the preparation of benzimidazo[1,2-a] benzimidazoles UDC IRELAND LIMITED (IE) 2020-02-25 US disclosed
EP-1749859-B1 CURABLE COMPOSITION KANEKA CORP (JP) 2019-09-11 EP disclosed
EP-1746134-B1 CURABLE COMPOSITION WITH IMPROVED CURABILITY AND ADHESIVENESS KANEKA CORP (JP) 2019-09-04 EP disclosed
EP-1746135-B1 CURABLE COMPOSITION KANEKA CORP (JP) 2019-05-29 EP disclosed
EP-1749857-B1 CURABLE COMPOSITION KANEKA CORP (JP) 2019-03-27 EP disclosed
US-20180170936-A1 PROCESS FOR THE PREPARATION OF BENZIMIDAZO[1,2-A] BENZIMIDAZOLES UDC IRELAND LIMITED (IE) 2018-06-21 US disclosed
US-5079206-A For obtaining high molecular weight/narrow distribution addition homo- or copolymers by controlled bulk polymerization; silcon, germanium or tin organic compounds; cocatalysts IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-01-07 US disclosed
EP-0463774-A2 Catalysts IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-01-02 EP disclosed
EP-0413464-A2 Catalysts IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1991-02-20 EP disclosed
EP-0413465-A2 Catalysts IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1991-02-20 EP disclosed
EP-0405787-A2 Catalysts IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1991-01-02 EP disclosed
EP-0405786-A2 Catalysts IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1991-01-02 EP disclosed
EP-0405785-A2 Catalysts IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1991-01-02 EP disclosed
US-4956428-A POLYMERIZATION OF ACRYLIC OR MALEIMIDE MONOMER WITH ORGANOSILICON, ORGANOTIN, ORGANOGERMANIUM INITIATORS, COORDINATION CATALYST IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-09-11 US disclosed
EP-0329330-A2 Polymerisation process IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1989-08-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10570136-B2 Process for the preparation of benzimidazo[1,2-a] benzimidazoles CYP3A4, CYP2C19, CYP1B1 TDP1 2367/4885FFAR3 4534/4885ALDH1A1 57/4885
US-20180170936-A1 PROCESS FOR THE PREPARATION OF BENZIMIDAZO[1,2-A] BENZIMIDAZOLES CYP3A4, CYP2C19, CYP1B1 TDP1 2367/4885FFAR3 4534/4885ALDH1A1 57/4885
US-20100168404-A1 Metal Complex Compositions and Methods for Making Metal-Containing Films CAD, VCAM1, VCL TDP1 2790/4885FFAR3 3094/4885ALDH1A1 358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.